[Cemiplimab in association to chemotherapy in advanced non-small cell lung cancer]

Bull Cancer. 2023 Oct;110(10):983-984. doi: 10.1016/j.bulcan.2023.05.008. Epub 2023 Jul 25.

[Article in French]

Authors

Adrien Rousseau¹, Édouard Auclin²

Affiliations

¹ Gustave-Roussy Cancer Campus, Department of Cancer Medicine, Villejuif, France. Electronic address: [email protected].
² AP-HP, hôpital européen Georges-Pompidou, université Paris Cité, centre, Medical Oncology Department, Paris, France.

PMID: 37500386
DOI: 10.1016/j.bulcan.2023.05.008

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Lung Neoplasms* / drug therapy
Skin Neoplasms*

Substances

cemiplimab
Antibodies, Monoclonal, Humanized